Research progress of RNAi in tumor treatment

Abstract

ZHAO Xiao-Yan, SUN Li-Xin. Research progress of RNAi in tumor treatment[J]. Journal of International Oncology, 2014, 41(3): 177-179.

［1］ Wu JF, Shen W, Liu NZ, et al. Downregulation of Dicer in hepatocellular carcinoma［J］. Med Oncol, 2011, 28(3): 804-809. ［2］张艾芃. HPV16/18 E6/E7基因沉默对SiHa/HeLa细胞生物学行为影响的研究［MI］. 北京：中国人民解放军军医进修学院, 2012. ［3］ Huanwen W, Zhiyong L, Xiaohua S, et al. Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminininduced phosphorylation of FAK in pancreatic cancer cell lines［J］. Mol Cancer, 2009, 8:125. ［4］ Lv A, Li Z, Tian X, et al. SKP2 high expression, KIT exon 11 deletions, and gastrointestinal bleeding as predictors of poor prognosis in primary gastrointestinal stromal tumors［J］. PLoS One, 2013, 8(5):e62951. ［5］王海燕, 谭丽莉, 江彩玉, 等. 应用siRNA技术探讨MCF-7乳腺癌细胞分泌的VEGF对树突状细胞的影响［J］.中国生物化学与分子生物学报， 2009, 25(4): 358-363. ［6］岳丽玲, 樊丽, 牛英才, 等. RNA干扰敲减FucTⅦ表达抑制人结肠癌细胞HT-29和HUVECs的粘附能力［J］. 中国生物化学与分子生物学报, 2010, (3):290-294. ［7］崔欲晓, 刘民, 李欣，等. RNA干扰抑制癌胚抗原表达对结肠癌细胞增殖的影响［J］. 中国生物化学与分子生物学报, 2010, 25(1):78-82. ［8］ Chen L, Hu L, Chan TH, et al. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1like (CHD1L) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival［J］. Hepatology, 2009, 50(1):122-129. ［9］ Chen L, Chan TH, Yuan YF, et al. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients［J］. J Clin Invest, 2010, 120(4):1178-1191. ［10］ Boumela I, Assou S, Haouzi D, et al. Developmental regulated expression of anti-and pro-apoptotic BCL-2 family genes during human early embryonic development［J］. Curr Med Chem, 2013, In press. ［11］魏建国. siRNA干扰Survivin对人胃癌SGC-7901细胞的影响［MI］. 衡阳：南华大学, 2011. ［12］ Chen Z, Ma T, Huang C, et al. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells［J］. Cell Signal, 2013, 25(12): 2693-2701. ［13］ Yang W, Sun T, Cao J, et al. Hypoxiainducible factor-1α downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and enhances radiosensitivity in chemical hypoxic human hepatoma SMMC-7721 cells［J］. Cancer Biother Radiopharm, 2011, 26(5):565-571. ［14］ Kang Y, Hu W, Ivan C, et al. Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer［J］. J Natl Cancer Inst, 2013, 105(19):1485-1495. ［15］ Tsai CL, Wu HM, Lin CY, et al. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase(FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα)［J］. PLoS One, 2013, 8(9):e72999. ［16］ Chai L, Qiao Z, Wang J, et al. Optimization and establishment of RNA interferencemediated knockdown of the progestagen-associated endometrial protein gene in human metastatic melanoma cell lines［J］. Mol Med Rep, 2013, 8(5):1390-1396. ［17］ Tanaka T, Mangala LS, Vivas-Mejia PE, et al. Sustained small interfering RNA delivery by mesoporous silicon particles［J］. Cancer Res, 2010, 70(9):3687-3696.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Research progress of RNAi in tumor treatment

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments